3187 results for «786»
3187 results
Innovations in coronary disease, diagnosis and treatment
18 May 2023 – From EuroPCR 2023
Join the panelists as they present a series of innovations in coronary disease. Amplify your insight into this vital topic and uncover an array of novelties in diagnosis and treatment.
PFO closure: safety, challenging anatomies and complications
17 May 2023 – From EuroPCR 2023
Disocover these cases to master PFO closure! Understand indications and patient selection, execute safe procedures, and navigate pitfalls with effective management strategies.
Hostile vascular access for large catheters
17 May 2023 – From EuroPCR 2023
This case-based session will help you learn how to better manage ilio-vascular complications, either by radial or femoral access, and learn more about how to use your peripheral toolbox.
Managing high-bleeding risk in case examples
18 May 2023 – From EuroPCR 2023
In these slides, discover techniques to assess bleeding and thrombotic risk in PCI patients, explore antithrombotic options, and implement strategies for risk minimisation.
Current trends in the invasive treatment of pulmonary embolism
18 May 2023 – From EuroPCR 2023
Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...
TAVI troubles - The role of Nurses and Allied Professionals
18 May 2023 – From EuroPCR 2023
In these slides, gain insights into potential TAVI issues, learn to anticipate and manage complications, and explore the pivotal role of NAP\'s.
Real-world outcomes with the PASCAL Platform in TR
03 Dec 2021
The PASCAL platform, comprising the PASCAL and PASCAL Ace implants, received its CE mark for TR in May 2020 and has been shown to be an effective and safe treatment option for patients with TR.3,4,6 Professor Jörg Hausleiter and Dr Mirjam Wild now describe their single-centre experience...
